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Abstract
Background: Chronic back pain is a major public health problem and the primary reason patients
seek acupuncture treatment. Therefore, an objective assessment of acupuncture efficacy is critical
for making informed decisions about its appropriate role for patients with this common condition.
This study addresses methodological shortcomings that have plagued previous studies evaluating
acupuncture for chronic low back pain.
Methods and Design: A total of 640 participants (160 in each of four arms) between the ages of
18 and 70 years of age who have low back pain lasting at least 3 months will be recruited from
integrated health care delivery systems in Seattle and Oakland. They will be randomized to one of
two forms of Traditional Chinese Medical (TCM) acupuncture needling (individualized or
standardized), a "control" group (simulated acupuncture), or to continued usual medical care. Ten
treatments will be provided over 7 weeks. Study participants and the "Diagnostician"
acupuncturists who evaluate participants and propose individualized treatments will be masked to
the acupuncture treatment actually assigned each participant. The "Therapist" acupuncturists
providing the treatments will not be masked but will have limited verbal interaction with
participants. The primary outcomes, standard measures of dysfunction and bothersomeness of low
back pain, will be assessed at baseline, and after 8, 26, and 52 weeks by telephone interviewers
masked to treatment assignment. General health status, satisfaction with back care, days of back-
related disability, and use and costs of healthcare services for back pain will also be measured. The
primary analysis comparing outcomes by randomized treatment assignment will be analysis of
covariance adjusted for baseline value. For both primary outcome measures, this trial will have 99%
power to detect the presence of a minimal clinically significant difference among all four treatment
groups and over 80% power for most pairwise comparisons. Secondary analyses will compare the
proportions of participants in each group that improve by a clinically meaningful amount.
Conclusion: Results of this trial will help clarify the value of acupuncture needling as a treatment
for chronic low back pain.
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Background
Back pain is one of the most important health problems
in developed countries. More than 50% of adults are
bothered by back pain each year [1] and 70% to 80% of
adults are afflicted by it at some time in their lives [2].
Back symptoms are the leading cause of visits to ortho-
pedic surgeons and neurosurgeons and the second leading
symptomatic reason for visits to all physicians [3]. Back
pain is the most costly ailment of working-age adults [4].
An estimated $25 billion are spent on personal medical
care for back pain every year and compensation and lost
productivity costs are much higher [5].
Back pain patients are often dissatisfied with conventional
medical care [6], especially in comparison to care pro-
vided by non-MD's including CAM practitioners [7-10].
Back pain is the leading primary reason for visits to
licensed acupuncturists, representing about 1 in 7 visits
[11], and acupuncturists consider it to be one of the con-
ditions for which acupuncture is most effective [12].
Despite numerous published randomized trials evaluat-
ing acupuncture as a treatment for chronic low back pain,
the efficacy and effectiveness of acupuncture for this com-
mon problem remains unclear. The 1997 NIH Consensus
Development Panel on Acupuncture noted "many of
these studies provide equivocal results because of design,
sample size, and other factors. The issue is further compli-
cated by inherent difficulties in the use of appropriate
controls, such as placebo and sham acupuncture groups"
[13]. Other reviews published before the study protocol
described in this manuscript was proposed (2002) also
noted the poor quality of research in this area and urged
that scientifically rigorous studies be conducted [14-16].
This study was designed to avoid the methodological
shortcomings that have plagued previous studies, includ-
ing inadequate acupuncture treatments, very small sam-
ple sizes, failure to include long-term outcome measures
and high rates of loss to follow-up.
Our primary aims are to answer the following questions:
1) Is acupuncture needling more effective than usual medical
care for reducing dysfunction or symptom bothersomeness due
to chronic low back pain?
We hypothesize that acupuncture needling (both
standardized and individualized) will be more effec-
tive than usual medical care.
2) Is acupuncture needling more effective that non-insertive
simulated acupuncture for reducing dysfunction or symptom
bothersomeness due to chronic low back pain?
We hypothesize that standardized acupuncture nee-
dling will be more effective than non-insertive simu-
lated needling.
3) Is individualized acupuncture needling more effective than
standardized acupuncture needling for reducing dysfunction or
symptom bothersomeness due to chronic low back pain?
We hypothesize that individualized acupuncture nee-
dling will be more effective than standardized acu-
puncture needling.
Our secondary aims are to compare the effects of these
four treatments on general health status, patient satisfac-
tion with care, days of restricted activity due to back prob-
lems, and costs and utilization of services.
By addressing the methodological shortcomings of previ-
ous studies, this trial will clarify the extent to which acu-
puncture can diminish the effect of chronic low back pain
on patient functioning and symptoms. Because chronic
back pain is a major public health problem and the top
reason patients seek acupuncture treatment, an unambig-
uous assessment is critical for making informed decisions
about the most appropriate role for acupuncture in care
for back pain.
Methods and design
Overview
Eligible participants at two sites will be randomized
equally to one of four treatments: individualized acu-
puncture point stimulation, standardized acupuncture
point stimulation, non-insertive simulated acupuncture
point stimulation, or usual care (Figure 1). Participants in
all three "acupuncture" arms will receive 10 "treatments"
involving stimulation of acupuncture points over a 7-
week treatment period (two treatments per week for 3
weeks, weekly treatments for 4 weeks).
The acupuncture provided will be in accordance with the
principles of Traditional Chinese Medicine (TCM) in
terms of point selection and needling details. Although
many styles of acupuncture are used in the U.S., we
selected TCM because it appears to be the most commonly
practiced [11,17] is the basis of the national certification
exam for non-physician acupuncturists, and is the foun-
dation of non-physician acupuncturist training in the
states in which this trial is being conducted. The treat-
ments will be provided by licensed acupuncturists, the
group that provides the vast majority of acupuncture treat-
ments in the United States.
In addition to the assigned treatments, all participants will
receive a high-quality book about self-management ofTrials 2008, 9:10 http://www.trialsjournal.com/content/9/1/10
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back pain and will retain access to the health care services
to which they are entitled by their insurance coverage.
Participants will be followed for a one-year period follow-
ing randomization and primary and secondary outcomes
will be assessed by telephone interviewers masked to
treatment assignment after 8, 26, and 52 weeks. The pri-
mary outcome will be dysfunction due to back pain and
bothersomeness of back pain. Secondary outcomes will
include general health status, satisfaction with back care,
days of restricted activity, and use and costs of back-
related health care for the year following randomization.
Bias will be minimized by a clinical protocol designed to
offer maximum possible masking in a study of a physical
procedure such as acupuncture. Although full double
masking is not possible, this design permits masking of
the assessor of outcomes and substantial masking of par-
ticipants and the acupuncturist prescribing a treatment.
Participants in the three "acupuncture" groups will know
only that they will receive one of several methods of stim-
ulating acupoints.
We will perform an intention-to-treat analysis of the data,
i.e., the analysis will be by randomized assignment
regardless of participation in treatment sessions. This trial
was preceded by a pilot trial to assess the feasibility of a
full-scale trial. The pilot study demonstrated the feasibility
of carrying out a full-scale trial, provided estimates of
recruitment rates, follow-up rates, and sample size
Study Design Figure 1
Study Design. Process of recruitment, randomization to treatment, treatment provision, and outcomes assessment.
Randomize 640 participants 
Identify patients with chronic low 
back pain and confirm willingness to 
participate in trial 
Individualized 
Needling 
plus Self-care 
Book 
(n=160) 
Standardized 
Needling 
plus Self-care 
Book 
(n=160)
Usual Care  
plus Self-care 
Book 
 (n=160) 
Outcomes assessed at 8, 26, and 52 weeks by masked telephone interviewer 
10 treatments provided over 7 weeks 
Simulated
Needling 
plus Self-care 
Book 
(n=160)Trials 2008, 9:10 http://www.trialsjournal.com/content/9/1/10
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requirements, and helped us optimize the clinical proce-
dures [18].
Study population
This study will focus on patients between 18 and 70 years
of age with non-radicular chronic low back pain of
mechanical origin (as opposed to infectious, neoplastic,
or inflammatory causes). There are many potential causes
of low back pain, but in most cases, a precise pathoana-
tomic diagnosis is unattainable because of the weak asso-
ciations among symptoms, pathoanatomic changes, and
imaging results.
Inclusion and exclusion criteria
Entry inclusion and exclusion criteria (Table 1) were
developed with the goal of maximizing enrollment of
appropriate participants while excluding patients who
have low back pain of a specific (e.g., spinal stenosis) or
complicated (e.g., due to a medical condition) nature, for
whom acupuncture is contraindicated (e.g., clotting disor-
ders), or whose medical conditions might make it difficult
to receive the treatments (e.g., gross obesity or severe psy-
chiatric conditions). These criteria are intended to exclude
patients with medical conditions that might contribute to
an increased risk of a severe adverse event, would not
allow for fully informed consent, or might lead to misin-
terpretation of the outcomes (e.g., multiple sclerosis or
diabetes whose neurological symptoms might interfere
with pain sensation). To maximize the credibility of our
simulated acupuncture treatment, we will also exclude
people who have had acupuncture treatment in the past
because such individuals may be more able to distinguish
simulated from actual acupuncture.
Recruitment procedures
Members of Group Health Cooperative in Seattle and Kai-
ser Permanente Northern California in Oakland whose
visits to healthcare providers resulted in diagnoses con-
sistent with non-specific low back pain will be identified
from the health plans' automated visit data. Three to 12
months after their visit, potential participants will be
mailed a letter that explains the study, describes eligibility
requirements, and invites participation. Members inter-
ested in participating will sign and return a statement
indicating their willingness to be contacted by study staff.
An interviewer will then phone the members to answer
questions and determine eligibility using a computer pro-
gram to guide the members through a series of screening
questions. If eligible, the study staff guides the patient
through the consent process. Once written consent is
obtained, an interviewer will contact the potential partic-
ipant to administer the baseline questionnaire. If still will-
ing to participate, participants will be randomized to one
of the four groups. If the participant is randomized to acu-
puncture, the interviewer will schedule the first two acu-
puncture appointments.
Table 1: Inclusion and exclusion criteria
Inclusion criteria
Participant plans to continue enrollment in health plan
Between 18 and 70 years of age
At least one primary care visit for back pain within the past 3–12 months
Non-specific, uncomplicated low back pain, i.e., ICD-9 codes:
724.2 Lumbago
724.5 Backache, unspecified
724.8 Other symptoms referable to back
846.0-9 Sprains and strains, sacroiliac
847.2 Sprains and strains, lumbar
847.3 Sprains and strains, sacral
847.9 Sprains and strains, unspecified site of the back
Physician willing to have patients included in the study
Lives within 45 minutes travel time from study clinic
Exclusion criteria
Previous acupuncture for any reason
Low back pain lasting less than 3 months
Mild symptoms (less than 3 on 0 to 10 pain bothersomeness scale)
Specific diseases that could be cause of back pain (metastatic cancer, discitis, herniated disc, vertebral fracture, spinal infection, osteitis condensans 
ilii, severe or progressive scoliosis, spinal stenosis, spondylolisthesis, ankylosing spondylitis)
Complicated back problems (sciatica, back surgery in prior 3 years)
Other disabling chronic conditions that might confound treatment effects or interpretation of data (e.g., disabling heart or lung disease, diabetic 
neuropathy, active hepatitis, fibromyalgia, rheumatoid arthritis)
Acupuncture contraindicated or safety not confirmed (clotting disorders, on anticoagulant therapy, heart pacemaker, pregnancy, seizure disorder)
Medico-legal issues (seeking or receiving compensation/litigation for back pain)
Conditions possibly making consenting or treatment difficult (paralysis, inability to lie prone for 45 minutes, major psychoses, dementia, scheduling 
conflicts, severe vision or hearing problems, lack of transportation, unable to read or speak English)Trials 2008, 9:10 http://www.trialsjournal.com/content/9/1/10
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If necessary, recruitment will be supplemented by adver-
tising the study in the health plan's quarterly magazine,
on its website, on bulletin boards in the health plans'
medical centers, and by placement on the NIH clinical tri-
als website (clinicaltrials.gov) Finally, if these methods
fail to achieve recruitment goals, recruitment letters will
be sent to randomly-selected health-plan members with-
out a recent clinic visit for low back pain and who are not
known to meet an exclusion criterion.
Randomization to treatment groups
Separate randomization files will be created for each of
the two sites. The random group assignments will be
based on a block design where the block size is not con-
stant.
At the end of each baseline interview, participants will be
randomly assigned by computer to an acupuncture treat-
ment or to continued access to usual care. At the time of
randomization, the computer informs the Research Spe-
cialist and participant of assignment to an acupuncture
treatment or to usual care. The specific acupuncture treat-
ments participants are assigned to are only revealed to the
treating acupuncturist, immediately prior to treatment.
The random assignments cannot be viewed in advance
and cannot be changed after randomization.
Study treatments
In the three acupoint stimulation groups, participants will
be treated twice weekly for the first three weeks, and then
weekly for four weeks (a total of 10 treatments over seven
weeks). Ten treatments were chosen because over 75% of
the acupuncturists we surveyed believed 8 treatments
would be necessary to treat chronic back pain [19]. These
treatments will be provided at no cost to study partici-
pants. Electrostimulation, moxibustion, herbs, and other
non-needle treatments and adjuncts will not be allowed
in this trial.
All participants will be mailed the Back Pain Help-
book[20]within a week of randomization. This evidence-
based manual for self-management of chronic back pain
includes information on managing flare-ups, physical
activity and exercise, and appropriate life-style modifica-
tions. From a practical viewpoint, we thought that giving
this book to participants in the usual care group would
minimize their disappointment at not receiving acupunc-
ture treatment and would therefore reduce losses to fol-
low-up. From a scientific viewpoint, providing the back-
care book to all participants permits assessment of the
efficacy of acupuncture beyond educational materials
alone.
In our pilot study, we found that we could successfully
mask participants to treatment group by using two acu-
puncturists who have minimal contact with each other: a
"Diagnostician acupuncturist" who prescribes an individ-
ualized treatment plan at each visit and a "Therapist acu-
puncturist" who provides the treatment to which the
participant was randomized. The Diagnostician acupunc-
turist will evaluate the participant at each visit using TCM
diagnostic techniques and will then write a prescription
for an individualized treatment designed to treat the back
pain and any underlying TCM "constitutional deficien-
cies" that could prevent the pain from resolving or give
rise to recurrences. A Research Specialist will then accom-
pany the participant from the Diagnostician acupunctur-
ist to the Therapist acupuncturist who will then
administer the randomly assigned treatment, interacting
minimally with the participant. Only one-third of partici-
pants randomized to an acupuncture treatment will actu-
ally receive the individualized treatment.
a) Individualized acupoint stimulation treatment
In this arm, the Therapist will administer the treatment
prescribed at the beginning of each visit by the Diagnosti-
cian. This treatment may include acupoints on any part of
the body that can be needled while the participant is lying
prone with his/her head in a face cradle. There are no con-
straints on number of needles, depth of insertion, or nee-
dle manipulation. This arm of the trial resembles clinical
practice where patients receive customized treatments that
may vary from visit to visit.
b) Standardized acupoint stimulation treatment
We previously developed a standardized needling pre-
scription (Table 2) considered effective for chronic low
back pain [18]. All acupoints will be needled with sterile
disposable 32-gauge needles (0.25-mm) for 20 minutes,
with stimulation at 10 minutes and again just prior to nee-
dle removal. A 1.5-inch needle will be used for most acu-
points, but longer needles will be used for acupoints
where deeper needling is appropriate. Needles will be
inserted to the depth typically recommended for that acu-
point, generally between 1 and 3 cm [21]. Because 90% of
the acupuncturists we surveyed felt that the phenomenon
of de qi was important to successful treatment of back pain
[19] it is an integral part of our treatment protocol. De qi
is usually described by the patient as a feeling of numb-
ness, heaviness or distention at the needle site [22]. How-
ever, there is also a biomechanical component to de qi that
is felt by the practitioner. This "needle grasp response"
occurs when tissue tightens around the inserted needle
and constricts its movement [23], and is poetically
described in the ancient texts as "the feeling of a fish biting
on a fishing line" [24]. Therapists will detect de qi using
the needle grasp response thereby avoiding discussion of
the needling sensation with the patient and maintaining
masking of the participant to treatment to the greatestTrials 2008, 9:10 http://www.trialsjournal.com/content/9/1/10
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extent possible. This approach will also be used in the
individualized treatment.
c) Non-insertive acupoint stimulation treatment (simulated 
acupuncture)
We previously developed and tested a simulated acupunc-
ture technique using a toothpick in a guidetube and deter-
mined that the technique was considered a credible
acupuncture treatment by participants with low back pain
[25] The acupuncturist will simulate insertion of needles,
using the toothpick and guidetube technique, at the same
eight acupoints used in the standardized treatment (Du3,
UB23-bilateral, low back ashi, UB40-bilateral, Ki3-bilat-
eral). Simulating insertion involves holding the skin taut
around each acupoint and placing a standard acupuncture
needle guidetube that contains a toothpick against the
skin. The acupuncturist then taps the toothpick gently,
twisting it slightly so that it feels to the participant like an
acupuncture needle grabbing the skin, and then quickly
withdraws both the toothpick and guidetube while keep-
ing his or her fingers against the skin for a few additional
seconds to imitate the process of inserting the needle to
the proper depth. All acupoints will be "stimulated" with
toothpicks at 10 minutes (i.e., the acupuncturist will
touch each acupoint with the tip of a toothpick without
the guidetube, rotate the toothpick clockwise and then
counterclockwise less than 30 degrees) and again at 20
minutes just before they are "removed." Location of the
correct acupoints for initial and subsequent stimulation
will be facilitated by having marked all the acupoints with
non-toxic ink prior to initiation of treatment. To simulate
withdrawal of the needle, the acupuncturist tightly
stretches the skin around each acupoint, presses a cotton
ball firmly on the stretched skin, then momentarily
touches the skin with a toothpick (without the guidetube)
and quickly pulls the toothpick away using the same hand
movements as in regular needle withdrawal. For verisimil-
itude, the Therapists will crinkle an empty needle wrapper
to simulate the sound of unwrapping needles before treat-
ment and will flick the side of the Sharps container after
needle withdrawal to simulate the sound of needle dis-
posal.
d) Usual care
We have included a usual care treatment arm to permit us
to determine if individualized or standardized acupunc-
ture offers advantages over standard care for chronic low
back pain. Members of this group (as well as members of
the three acupuncture treatment groups) will continue to
receive the medical care they would have received in the
absence of the study. This typically involves continued use
of medications (mostly non-steroidal anti-inflammatory
medicines), and occasionally, provider visits.
Clinic sites
Acupuncture treatments will be performed in the Research
Clinics at the two study sites. The Diagnosticians and
Therapists will see participants in separate rooms. Thera-
pists' rooms will resemble a typical acupuncture treatment
room with a massage table for treatment and a table for
acupuncture supplies. This table will be screened off from
the massage table to prevent participants from looking at
the needles or non-insertive implements to be used in
their treatment.
Study acupuncturists
Licensed acupuncturists will be recruited and trained as
either Diagnosticians or Therapists and will function only
in their assigned role throughout the study. All acupunc-
turists will be experienced TCM practitioners. We will
require Diagnostician acupuncturists to have at least five
years experience and Therapists to have at least three years
experience with an emphasis on the treatment of muscu-
loskeletal pain. All acupuncturists will need to agree to
strictly adhere to the study protocol and to complete the
rigorous training program developed in the pilot study. In
addition, the Therapist acupuncturists will need to be
comfortable administering all three treatments.
Table 2: Standardized acupoint stimulation treatment
Acupoints Location Major Indications and Actions. [21,38]
Du3 (Yaoyang-guan) Midline of the lower back, just below the spinous process of the fourth 
lumbar vertebra
Lumbosacral pain, motor impairment, numbness 
and pain of legs, other (e.g., seizures)
UB23 (Shenshu) 1.5 inches lateral to lower border of the spinous process of the second 
lumbar vertebra (bilateral point)
Low back pain, principal point to strengthen the 
"Kidneys", other (e.g., weakness of knee)
Low back ashi Any tender point in the area between a horizontal line just below T12 and 
a horizontal line at the tip of the coccyx and extending to the outer 
contour of the body (as assessed by the Diagnostician acupuncturist)
Used according to the concept that "where 
there is pain, there is an acupuncture point"
UB40 (Weizhong) Back of the knee in the midpoint of the transverse crease of the popliteal 
fossa (bilateral point)
Low back pain, motor impairment of hip joint, 
"activation of the UB channel"
Ki3 (Taixi) On the foot, depression between the medial malleolus and tendo 
calcaneus (bilateral point)
Lumbar pain, strengthen lumbar spine, 
"nourishes Kidney Yin and tonifies Kidney 
Yang", other (e.g., insomnia)Trials 2008, 9:10 http://www.trialsjournal.com/content/9/1/10
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Training and monitoring of acupuncturists and clinic staff
Prior to beginning the study, Acupuncturist Diagnosti-
cians, Acupuncturist Therapists and Research Assistants
will undergo intensive and customized training in the
clinical protocol. There will be "dress rehearsals" with
scripted "participants" to ensure that the clinical treat-
ment team is able to adhere to the protocol under a variety
of challenging participant scenarios. Much of the commu-
nication between the Therapists and the participants and
between the Research Assistants and the participants is
scripted and we have standard answers to commonly
asked questions. The Research Assistants will use a special
clinic visit form to document deviations from protocol by
themselves or by the acupuncturists. Site visits will occur
about 4 and 16 months after treatment begins to ensure
continued adherence to study procedures.
Assessment of outcomes
A core set of recommended outcome measures [26] cover-
ing five important domains will be assessed: back-related
dysfunction, pain, general health status, disability and
patient satisfaction. The primary efficacy/effectiveness
outcomes are pain and dysfunction. There will be no
physical assessments or laboratory tests because these
have not been found to be useful for assessments of out-
comes in studies of mechanical back pain. The primary
assessment will be the 8-week telephone interview.
Table 3 below summarizes the categories of questions that
are included in the baseline and follow-up question-
naires.
Primary measures of efficacy/effectiveness
The modified Roland-Morris Disability Questionnaire
will be used to measure back-related patient dysfunction
[26,27]. This instrument, which asks 23 yes/no questions,
takes approximately five minutes to complete. A compos-
ite score is obtained by summing up the number of "yes"
responses, so the total scores range from 0 to 23. It has
been found to be reliable, valid and sensitive to clinical
changes [27-32] and is well suited for telephone adminis-
tration.
Because there are individuals who are very bothered by
even a small amount of pain and others who are not both-
ered by even moderate pain, our primary measure of
symptoms assesses participants' perceptions of the impact
of pain on their lives rather merely assigning a pain sever-
ity score. Thus, participants will be asked to rate how
bothersome their low back pain has been during the past
week on a 0 to 10 scale where 0 represents "not at all both-
ersome" and 10 "extremely bothersome". This measure
appears to have substantial construct validity – i.e., it is
highly correlated with measures of function and other
outcome measures [27].
Both primary outcomes will be measured at baseline and
during the 8, 26 and 52 week follow-up interviews. The
trial's primary endpoint will be the 8 week follow-up, one
week after completion of the 10 acupuncture treatments.
All interviews will be conducted using computer-assisted
telephone interviews (CATI).
Table 3: Content of baseline and follow-up questionnaires
Measures Baseline 8-Week 26-Week 52-Week
Sociodemographic characteristics x
Back pain history x
* Roland Disability Questionnaire (dysfunction) xx x x
* Bothersomeness of low back pain xx x x
Satisfaction with back care x x x
General Health Status (SF-36) x x x
Disability days xx x x
Medication use xx x x
Worry about back problem x x x x
Exercise (Back-related, general) x x x
Confidence in ability to self-manage future back pain x x x
Expectations of treatment x
Knowledge of acupuncture x
Adverse experiences x
Perceptions of acupuncture experience (acupoint stimulation participants only) x
Perceptions of book on self-care xx
Use of non-HMO services for back pain x x x
Use and cost of HMO services for back pain [from automated HMO databases]
* Co-primary outcome measuresTrials 2008, 9:10 http://www.trialsjournal.com/content/9/1/10
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Secondary measures of efficacy/effectiveness
General health status will be measured using the well-val-
idated SF- 36 [33] that has been recommended for use in
studies of back pain [26,34]. The SF-36 measures eight
health concepts: 1) limitations in physical activities
because of health problems; 2) limitations in social activ-
ities because of physical or emotional problems; 3) limi-
tations in usual role activities because of physical health
problems; 4) bodily pain; 5) general mental health (psy-
chological distress and well-being); 6) limitations in usual
role activities because of emotional problems; 7) vitality
(energy and fatigue); and 8) general health perceptions.
Satisfaction with information given about the cause of the
back problem, treatments received, and overall care will
be measured using three separate questions, each with a 5-
point Likert scale (ranging from very satisfied to very dis-
satisfied). Days of restricted activity due to back problems,
a surrogate for disability, will be measured with a back-
pain specific modification of 3 National Health Interview
Survey questions about the number of half-days spent in
bed, home from work or school, or cutting down on usual
activities due to illness or injury during the past week [35].
Efficacy will be determined by comparing outcomes
among the four treatments arms, adjusting for baseline
values. The analytic plan is described below.
Measures of health care resource use
Participants' use of health care for back pain during the
year following randomization will be determined from
automated utilization data, interview data on out-of-plan
utilization, and records for each visit to the study acu-
puncturists. The automated utilization data provide com-
plete information about all provider visits and
hospitalizations at health plan facilities or paid for by the
health plan. Visits for back pain can be identified by the
diagnosis listed for every visit and hospitalization. Imag-
ing of the lower back can also be identified by specific pro-
cedure codes. Our previous studies have found that the
automated data are as reliable as chart data for identifying
provider visits and imaging for back pain, but much less
costly.
Visits to non-study acupuncturists and providers not cov-
ered by the health plan will be estimated from the inter-
view data for the time period since the previous interview.
In other words, the 8-week interview will request informa-
tion about out-of-plan utilization since participants were
randomized to study treatment, the 26-week interview
will ask about the previous 18 weeks, and so forth. To
increase the accuracy of response, we will mail partici-
pants Health Care Utilization logs to track visits they
make for their back pain shortly after randomization and
after 8 and 26 weeks. This will permit determination of
the percentage of participants in each treatment group
who had any visits for low back pain during and following
the intervention period, as well as estimation of the mean
number of visits. Current use of medications of all types
for low back pain will be captured in the follow-up inter-
views.
Costs of back-related care will be estimated by assigning
dollar values to each service. Costs of specific services
(e.g., visits, imaging studies, medications) will be deter-
mined using data from both sites' cost management infor-
mation systems which define cost based on standard
relative value units (RVUs) assigned to actual department
RVUs produced. Costs of the acupuncture interventions
will be distinguished from the costs of all other back pain-
related services to permit separate comparisons among
the treatment groups of the costs of the interventions
themselves, of the non-intervention back care costs during
the 7-week treatment period, and of the total back pain-
related costs incurred over the 45 week period between
completion of the study interventions and the end of the
52 week follow-up period.
Protection of human subjects and assessment of 
safety
Protection of human subjects
This study protocol was approved by the Institutional
Review Boards of Group Health Cooperative and Kaiser
Foundation Research Institute.
Data safety monitoring board
The Data Safety Monitoring Board (DSMB) established by
the National Center for Complementary and Alternative
Medicine to monitor large trials will monitor the progress
of the trial and review safety data.
Adverse events
Participants will be asked about adverse experiences at
each clinic visit and during the 8-week telephone inter-
views. We will define an adverse experience as any unfavo-
rable and unintended sign, symptom or disease
temporally associated with the use of the acupuncture
treatments, which could reasonably be related to the pro-
cedure. Because acupuncture has relatively short-term
physiological effects, we will not report adverse events
that first manifest more than two weeks after a partici-
pant's final acupuncture treatment (or more than 9 weeks
after randomization for the usual care control group). Any
adverse event that is life-threatening or results in death,
hospitalization, a persistent or significant disability/inca-
pacity, a congenital anomaly/birth defect, or cancer will
be promptly reported to the DSMB.Trials 2008, 9:10 http://www.trialsjournal.com/content/9/1/10
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Stopping rules
The trial will be stopped if the Data Safety Monitoring
Board (DSMB) believes there is an unacceptable risk of
serious adverse events in one or more of the treatment
arms. No interim analyses of efficacy are planned to there
are no formal stopping rules for efficacy or futility.
Statistical issues
Sample size and the detectable difference
The sample size was selected to have adequate power to
detect a clinically significant difference of 2.0 points
between groups on the Roland Disability scale. Our target
sample size of 640 randomized individuals (160 per
group) was computed using assumptions described
below. Assuming 10% loss to follow-up for each group,
there will be outcome data for 144 participants per group.
The power of the overall analysis depends on how the four
means are distributed. We used the pilot data to estimate
the distribution of the means for the four groups and then
computed an effect size that was used in the omnibus
power calculation.
In the proposed analysis we will first determine if there is
an overall difference among the four treatment groups
using a two-sided significance level of 0.05. With 144 per
group, this omnibus F-test will have 99% power for
detecting a statistically significant difference among the
four treatment means given the effect size obtained in the
pilot study. If this omnibus test is statistically significant,
we will compare specified pairs of means as indicated in
the proposal. Because this will involve multiple post-hoc
comparisons, we will use the Tukey-Kramer multiple com-
parisons procedure [36] to allow for all possible pairwise
comparisons holding the overall α = 0.05. We will not
consider a pairwise difference between the means to be
statistically significant unless the t-value exceeds 2.61,
instead of the usual 1.96.
Both primary outcomes (Roland Disability Questionnaire
and bothersomeness of low back pain) are tested at the
0.05 level because they address separate scientific ques-
tions. The analyses of covariance of the 8-week pilot data
provided estimates of the standard deviations of the pri-
mary outcome measures adjusted for pre-randomization
baseline values: Roland SD = 4.71 and Bothersomeness
SD = 2.73. Using these assumptions, the power to detect a
pairwise difference of 2.0 Roland units is 84%, adjusted
for multiple comparisons. For the bothersomeness out-
come, for which a difference of 1.5 points is considered
minimally clinically significant, we will have 98% power
to detect a difference of this magnitude. Thus, if our
assumptions are correct, 160 participants per group will
provide adequate power to detect the smallest clinically
meaningful differences on both of our primary outcome
measures even after adjustment for multiple pairwise
comparisons.
In our secondary analyses, we will compare the propor-
tions of participants in each treatment group who experi-
ence clinically significant improvement on our primary
outcome measures.
We plan to conduct subgroup analyses of gender, study
site, and race/ethnicity that will include an overall com-
parison of the four groups followed by specific pairwise
comparisons. Power for some of these comparisons will
be limited. While we will test a site by treatment interac-
tion to determine if the treatment effects differ across the
two sites, this test will only be sensitive to very pro-
nounced effect modification by site.
In summary, we have high power to find an overall differ-
ence among the four groups even in some of the planned
subset analyses. Although powered to detect clinically sig-
nificant difference on the Roland Disability scale, the
resultant sample size will provide ample power for our
other primary outcome, bothersomeness of back pain,
even in pairwise comparisons adjusted for multiple com-
parisons. Because our estimates are conservative, we are
very likely to have adequate power even if the assump-
tions on which our power estimates are based prove incor-
rect. In addition, the proposed sample sizes will permit us
to explore whether the findings apply equally to women
and men and to different racial groups.
Statistical analysis
The power calculations are based on simple comparisons
of the follow-up scores at a single point in time (eight
weeks after randomization) with adjustment for baseline
values using analysis of covariance. We also plan to adjust
for other baseline characteristics. In a large randomized
trial, baseline values and other covariates are unlikely to
differ across randomized groups. However, for continu-
ous outcome data, inclusion of baseline covariates can
improve precision of the variance estimate and therefore
increase power. The covariates to be used in the final
model will be based on past experience and model fit as
assessed prior to inclusion of treatment group in the
model. We will use the Tukey-Kramer method to adjust
for multiple pairwise comparisons [36] across the four
groups and allow all pairwise comparisons to be con-
ducted holding the overall α = 0.05 fixed.
We will use an intent-to-treat approach to all analyses, i.e.
individuals will be analyzed by randomized group regard-
less of participation in any treatment sessions. This mini-
mizes biases that often occur when participants not
receiving assigned treatments are excluded from analyses.
Furthermore, we will adjust for geographic site as a mainTrials 2008, 9:10 http://www.trialsjournal.com/content/9/1/10
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effect. The standard linear regression model (ANCOVA) is
of the form:
Y(t) = β0 + β1 Baseline + α1 Grp1+ + α2 Grp2 + α3 Grp3 + θT 
z + ε
where response is at follow-up time t, baseline is the pre-
randomization value of the outcome measure, z is a vector
of covariates representing other variables being adjusted
for, including geographic site and, for some models, visits
to various providers for back pain as part of usual care.
The referent group is Usual Care in this model. We will
consider interactions of treatment and the baseline value
that would indicate that the effect of treatment depends
on status at baseline. We will also test for significant inter-
actions of treatment with other variables (e.g. site, race,
gender) to determine if treatment differences are modified
by these variables. The statistical model assumes that the
error terms are normally distributed. In previous studies
we have used transformations when this assumption was
not satisfied. However, given that these patients have
chronic back pain it is unlikely that most will return to a
level of no pain or dysfunction so floor effects are not
expected to be large. We will also investigate whether
there are differences among the treating acupuncturists by
inclusion of acupuncturist in the model as a random
effect.
If we find a significant overall difference among the four
groups for a particular outcome, we will localize the dif-
ference using pairwise comparisons in accordance with
our specific aims (see Section 2 Project Overview). We will
use the Tukey-Kramer procedure to adjust for multiple
comparisons while maintaining an overall significance
level of 0.05. Each specific aim will be addressed by a spe-
cific pairwise comparison.
Although this model evaluates differences at one time-
point it can be extended to include all follow-up times to
assess whether treatment effects change over time. This
would be indicated by significant time by treatment inter-
actions. For longitudinal analyses, we would use a gener-
alized estimating equation (GEE) approach to protect
against misspecification of the correlation within a partic-
ipant's scores over time. Such analyses can incorporate
every time point completed by a participant. However, it
is important to assess whether there is differential drop-
out by either assigned treatment or symptom or function
level. If differential drop-out occurs, we will use the
method of Little to rectify possible biases that could occur
[37].
We will also analyze secondary outcomes: costs of back
care, general health status (SF-36), pain intensity, disabil-
ity days, and satisfaction with care. An analysis of costs
may entail a transformation (e.g., log cost) but can be
modeled using linear regression. The model is similar to
the one described above except that we will not enter a
baseline value for costs in the model since this is
unknown. We will adjust for age and other factors that
may affect costs. For binary outcomes (e.g., participants
spending any days in bed due to their back pain during
the past week) we will use logistic regression. Despite the
multiplicity of analyses, we will focus our analyses on the
effects of the treatments on each of the five outcome
domains recommended for studies of low back pain [26].
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